March 29, 2024
Otsuka Pharmaceutical Co., Ltd.
Kyushu University
Kyoto University
National Hospital Organization Nagoya Medical Center
The Institute of Medical Science, The University of Tokyo
Keio University School of Medicine
Otsuka Pharmaceutical Co., Ltd. (Head Office: Tokyo; hereinafter "Otsuka Pharmaceutical") announced today that it has filed an application for marketing approval in Japan for a gene panel test for hematologic malignancies. The test was co-designed by Otsuka Pharmaceutical and the National Cancer Center Japan (Location: Tokyo; hereinafter "National Cancer Center") and developed through a joint research consortium with the National Cancer Center, Kyushu University (Location: Fukuoka Prefecture), Kyoto University (Location: Kyoto Prefecture), the National Hospital Organization Nagoya Medical Center (Location: Aichi Prefecture), the Advanced Clinical Research Center at The Institute of Medical Science, The University of Tokyo (Location: Tokyo), and the Keio University School of Medicine (Location: Tokyo).
Please see below for the full press release.